GPT and Hepatic fibrosis: This potential is further supported by our multivariable analyses which showed cT1 IQR to be less associated with circulating biomarkers of liver inflammation (e.g., AST and ALT) and cholestasis (e.g., GGT and ALP) than liver stiffness is, suggesting cT1 IQR may be less confounded by inflammation and cholestasis as a marker of liver fibrosis.